{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:47:27Z","timestamp":1774950447743,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ICB (Biomedical Science Institute of the CEU - Cardenal Herrera University)","award":["BC\/ICB-Santander 05\/12"],"award-info":[{"award-number":["BC\/ICB-Santander 05\/12"]}]},{"name":"Biomedical Science Institute of the CEU - Cardenal Herrera University","award":["BC\/ICB-Santander 06\/12"],"award-info":[{"award-number":["BC\/ICB-Santander 06\/12"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejmech.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T05:31:04Z","timestamp":1499491864000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"138","author":[{"given":"Jose I.","family":"Bueso-Bordils","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-9267","authenticated-orcid":false,"given":"Maria T.","family":"Perez-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Suay-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Duart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael V.","family":"Martin Algarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Lahuerta Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo M.","family":"Anton-Fos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-0250","authenticated-orcid":false,"given":"Pedro A.","family":"Aleman Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tips.2010.08.002","article-title":"The global need for effective antibiotics: challenges and recent advances","volume":"31","author":"Diaz-H\u00f6gberg","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"11 Suppl","key":"10.1016\/j.ejmech.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/aje\/kwr310","article-title":"Health care-associated infection outbreak investigations by the centers for disease control and prevention, 1946-2005","volume":"174","author":"Archibald","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","article-title":"Meticillin-resistant Staphylococcus Aureus (MRSA): global epidemiology and harmonisation of typing methods","volume":"39","author":"Stefani","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2017.07.010_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(05)70243-7","article-title":"Meticillin-resistant Staphylococcus aureus","volume":"5","author":"Boyce","year":"2005","journal-title":"Lancet infec. Dis."},{"issue":"21","key":"10.1016\/j.ejmech.2017.07.010_bib6","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMp1100251","article-title":"How Staphylococcus Aureus adapts to its host","volume":"364","author":"Lowy","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ejmech.2017.07.010_bib7","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.drudis.2016.06.013","article-title":"Khan, Descriptors and their selection methods in QSAR analysis: paradigm for drug design","volume":"21","author":"Danishuddin","year":"2016","journal-title":"Drug Discov. Today."},{"issue":"6","key":"10.1016\/j.ejmech.2017.07.010_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138620711795767866","article-title":"Integrating virtual screening and combinatorial chemistry for accelerated drug discovery","volume":"14","author":"Lopez-Vallejo","year":"2011","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"10.1016\/j.ejmech.2017.07.010_bib10","doi-asserted-by":"crossref","first-page":"23634","DOI":"10.1038\/srep23634","article-title":"3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors","volume":"6","author":"Fang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.07.010_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.compbiolchem.2015.09.009","article-title":"QSAR modeling of the antimicrobial activity of peptides as a mathematical function of a sequence of amino acids","volume":"59","author":"Toropova","year":"2015","journal-title":"Comput. Biol Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2017.07.010_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11224-012-0180-2","article-title":"The definition of the molecular structure for potential anti-malaria agents by the Monte Carlo method","volume":"24","author":"Toropov","year":"2013","journal-title":"Struct. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib13","series-title":"Topological Indices and Related Descriptors in QSAR and QSPAR","author":"Devillers","year":"1999"},{"key":"10.1016\/j.ejmech.2017.07.010_bib14","volume":"vol. 11","author":"Mannhold","year":"2000"},{"issue":"2","key":"10.1016\/j.ejmech.2017.07.010_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1573409911309020002","article-title":"Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships","volume":"9","author":"Ovidiu","year":"2013","journal-title":"Curr. Comput.-Aided Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2017.07.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-7439(96)00023-8","article-title":"Multivariate design and modeling in QSAR","volume":"34","author":"Eriksson","year":"1996","journal-title":"Chemom. Intell. Lab."},{"issue":"6\u20137","key":"10.1016\/j.ejmech.2017.07.010_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best Practices for QSAR Model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inf."},{"issue":"3","key":"10.1016\/j.ejmech.2017.07.010_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/cr0780006","article-title":"Some new trends in chemical graph theory","volume":"108","author":"Garc\u00eda-Dom\u00e9nech","year":"2008","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2017.07.010_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2004.03.012","article-title":"New hypoglycaemic agents selected by molecular topology","volume":"278","author":"Calabuig","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejmech.2017.07.010_bib20","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.3390\/ijms12129481","article-title":"Modeling natural anti-inflammatory compounds by molecular topology","volume":"12","author":"G\u00e1lvez-Llompart","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2017.07.010_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2008.07.003","article-title":"Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds","volume":"363","author":"Garc\u00eda-Dom\u00e9nech","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejmech.2017.07.010_bib22","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1021\/jm0580555","article-title":"Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays","volume":"49","author":"Duart","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2017.07.010_bib23","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/S0960-894X(03)00544-4","article-title":"Search compounds with antimicrobial activity by applying molecular topology to selected quinolones","volume":"13","author":"Mut-Ronda","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2017.07.010_bib24","doi-asserted-by":"crossref","first-page":"e92750","DOI":"10.1371\/journal.pone.0092750","article-title":"Molecular topology as novel strategy for discovery of drugs with Ab lowering and anti-aggregation dual activities for Alzheimer's disease","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.ejmech.2017.07.010_bib25","series-title":"MOLCONN-Z Software","author":"Hall","year":"1995"},{"key":"10.1016\/j.ejmech.2017.07.010_bib26","series-title":"Unidad de Investigaci\u00f3n de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular.; Facultad de Farmacia","author":"DESMOL13 software","year":"2000"},{"key":"10.1016\/j.ejmech.2017.07.010_bib27","series-title":"BMDP Statistical Software","author":"Dixon","year":"1990"},{"issue":"1","key":"10.1016\/j.ejmech.2017.07.010_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/0929867033368637","article-title":"Biological activity and synthetic methodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents","volume":"10","author":"Da Silva","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A\u00a0decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ejmech.2017.07.010_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2017.07.010_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1573409912666151126214242","article-title":"Topological model for the search of new antibacterial drugs. 158 theoretical candidates","volume":"11","author":"Bueso-Bordils","year":"2015","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ejmech.2017.07.010_bib32","unstructured":"Staphylococcus aureus CECT 5190, obtained from the Spanish Collection of Type Cultures (CECT). This strain corresponds to the bacteria S. aureus subsp. aureus Rosenbach 1884, which is included in the biological risk 2 group and is resistant to methicillin (MRSA). It was reconstituted in nutrient broth and then streaked on Trypticase Soy Agar (TSA)."},{"key":"10.1016\/j.ejmech.2017.07.010_bib33","series-title":"Procedimientos en Microbiolog\u00eda Cl\u00ednica. Recomendaciones de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","author":"Garc\u00eda","year":"2000"},{"issue":"6","key":"10.1016\/j.ejmech.2017.07.010_bib34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/ci00028a014","article-title":"Electrotopological state indices for atom types: a novel combination of electronic, topological, and valence state information","volume":"35","author":"Hall","year":"1995","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"issue":"13","key":"10.1016\/j.ejmech.2017.07.010_bib35","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1016\/j.bmcl.2006.03.103","article-title":"Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety","volume":"16","author":"Foroumadi","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2017.07.010_bib36","first-page":"927","article-title":"Correlations between topological features and physicochemical properties of molecules","volume":"93","author":"Jain","year":"1984","journal-title":"Proc. Indian Acad. Sci. Chem. Sci. Sci."},{"issue":"19","key":"10.1016\/j.ejmech.2017.07.010_bib37","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/acs.jmedchem.6b00472","article-title":"The \u201ccyclopropyl fragment\u201d is a versatile player that frequently appears in preclinical\/clinical drug molecules","volume":"59","author":"Talele","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2017.07.010_bib38","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/jm0497895","article-title":"A\u00a0prodrug approach toward the development of water soluble fluoroquinolones and structure-activity relationships of quinoline-3-carboxylic acids","volume":"47","author":"Baker","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib39","unstructured":"W.J. Kim, M.H. Park, J.D. Ha, K.U. Baik, Novel Quinolone Carboxylic Acid Derivatives and Processes for Preparing Same, European Patent n\u00ba 550016, 1993."},{"issue":"12","key":"10.1016\/j.ejmech.2017.07.010_bib40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0960-894X(99)00251-6","article-title":"Nitroquinolones with broad-spectrum antimycobacterial activity in\u00a0vitro","volume":"9","author":"Artico","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.010_bib41","unstructured":"U. Petersen, M. Schriewer, K. Grohe, H.J. Zeiler, K.G. Metzger, 7-Azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinoline Carboxylic Acids and 1,8-Naphthyridine Carboxylic Acids, Process for Their Preparation and Bactericidal Agents Containing Them. European Patent n\u00ba 241206 A2, 1986."},{"key":"10.1016\/j.ejmech.2017.07.010_bib42","unstructured":"M. Iwata, T. Kimura, Y. Fujiwara, K. Tetsushi., Quinoline-3-carboxylic Acid Derivatives, Their Preparation and Use. European Patent n\u00ba 203488 A2, 1987."},{"issue":"4","key":"10.1016\/j.ejmech.2017.07.010_bib43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jhet.5570260444","article-title":"Synthesis and ntibacterial activity of some 7-substituted 1-Ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acids: ethers, secondary amines and sulfides as C-7 substituents","volume":"26","author":"Ziegler","year":"1989","journal-title":"J.\u00a0Heterocycl. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2017.07.010_bib44","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/jm00149a003","article-title":"Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents","volume":"28","author":"Chu","year":"1985","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib45","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.bmcl.2010.07.006","article-title":"Synthesis and in\u00a0vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines","volume":"20","author":"Chai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.010_bib46","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cmdc.201200210","article-title":"Design, synthesis, and in\u00a0vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(Alkoxyimino)-2-(aminomethyl)azetidine moiety","volume":"7","author":"Lv","year":"2012","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.010_bib47","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1016\/S0040-4039(01)01385-5","article-title":"Microwave assisted amination of quinolone carboxylic acids: an expeditious synthesis of fluoroquinolone antibacterials","volume":"42","author":"Reddy","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2017.07.010_bib48","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1016\/j.tet.2010.02.046","article-title":"Substituted 2,5-diazabicyclo[4.1.0]heptanes and their application as general piperazine surrogates: synthesis and biological activity of a ciprofloxacin analogue","volume":"66","author":"Taylor","year":"2010","journal-title":"Tetrahedron"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T08:28:58Z","timestamp":1535617738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417305329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":48,"alternative-id":["S0223523417305329"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.010","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}